Tuberculosis is a communicable infectious disease caused by Mycobacterium tuberculosis and related members of the Mycobacterium complex, including the zoonotic agent Mycobacterium bovis. It is most commonly pulmonary but is capable of extrapulmonary involvement, affecting the lymph nodes, pleura, peritoneum, gastroi…
Tuberculosis is a communicable infectious disease caused by Mycobacterium tuberculosis and related members of the Mycobacterium complex, including the zoonotic agent Mycobacterium bovis. It is most commonly pulmonary but is capable of extrapulmonary involvement, affecting the lymph nodes, pleura, peritoneum, gastrointestinal tract, liver, and other sites, sometimes presenting as mass-like or pseudotumoral lesions. Transmission occurs chiefly through inhalation of airborne droplet nuclei expelled by individuals with active pulmonary disease. Infection may remain latent, with contained but viable bacilli and no symptoms, or progress to active disease; reactivation risk rises markedly with immunosuppression, particularly HIV co-infection. A major clinical challenge is drug resistance, including multidrug-resistant tuberculosis, frequently driven by mutations in the rpoB gene that confer rifampicin resistance. Diagnosis combines microbiological, molecular, immunodiagnostic, and imaging approaches, while management depends on prolonged multidrug regimens and coordinated control programmes to interrupt transmission. The journal publishes peer-reviewed research relevant to this area, with work addressing rpoB mutations and rifampicin resistance in patients co-infected with HIV, hepatic and gastrointestinal extrapulmonary tuberculosis, bovine tuberculosis immunodiagnosis and cytokine responses to M. bovis, assessment of national tuberculosis control programmes, patient knowledge of the disease, and the development of imaging agents and nanoadjuvant vaccination strategies. These themes span drug-resistant, extrapulmonary, and HIV-associated tuberculosis alongside diagnostic, vaccine, and programmatic research.
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
The 12 articles above have been cited 14 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
A sample of recent works citing this journal's research on Tuberculosis, linking to each citing work.